Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Gynecologic 1Dermatologic 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Parathyroid Diseases 1Neoplasms 1Margins of Excision 1Head and Neck Neoplasms 1Adenoma 1

Interventions

Cisplatin 47pembrolizumab 37Magnetic Resonance Spectroscopy 33Specimen Handling 27Radiotherapy, Intensity-Modulated 21Cetuximab 19Nivolumab 18Carboplatin 16Platinum 151,2-diaminocyclohexaneplatinum II citrate 15Radiotherapy 14Biopsy 12Paclitaxel 11Gemcitabine 10Docetaxel 10Surveys and Questionnaires 9Radiation 9Immunoglobulin G 7Disulfides 7toripalimab 6cemiplimab 6Ipilimumab 6Fluorouracil 6Bevacizumab 6dostarlimab 5atezolizumab 5Watchful Waiting 5Taxes 5Immune Checkpoint Inhibitors 5Drug Therapy 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Indocyanine Green × Head & Neck × 30 days × Clear all
NCT07149207 2026-05-12

Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

Medical University of South Carolina

Phase 2 Recruiting
30 enrolled
Head & Neck

Margins of Excision, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms

NCT06169735 2026-05-06

Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation

University of Alabama at Birmingham

Phase 4 Terminated
417 enrolled
Head & Neck

Adenoma, Parathyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡